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Abstract
Background: Oxymatrine, an isolated extract from traditional Chinese herb Sophora Flavescens Ait, has been
traditionally used for therapy of anti-hepatitis B virus, anti-inflammation and anti-anaphylaxis. The present study was
to investigate the anti-cancer effect of oxymatrine on human pancreatic cancer PANC-1 cells, and its possible
molecular mechanism.
Methods: The effect of oxymatrine on the viability and apoptosis was examined by methyl thiazolyl tetrazolium
and flow cytometry analysis. The expression of Bax, Bcl-2, Bcl-x (L/S), Bid, Bad, HIAP-1, HIAP-2, XIAP, NAIP, Livin and
Survivin genes was accessed by RT-PCR. The levels of cytochrome c and caspase 3 protein were assessed by
Western blotting.
Results: Oxymatrine inhibited cell viability and induced apoptosis of PANC-1 cells in a time- and dose-dependent
manner. This was accompanied by down-regulated expression of Livin and Survivin genes while the Bax/Bcl-2 ratio was
upregulated. Furthermore, oxymatrine treatment led to the release of cytochrome c and activation of caspase-3 proteins.
Conclusion: Oxymatrine can induce apoptotic cell death of human pancreatic cancer, which might be attributed
to the regulation of Bcl-2 and IAP families, release of mitochondrial cytochrome c and activation of caspase-3.
Background
Pancreatic cancer is one of the most common malignant
tumors worldwide. It can only be managed with surgical
treatment in limited cases, whereas the majority of cases
presented advanced tumors responds poorly to current
available medical therapies [1]. Similar to other tumor
types, insufficient cell death and/or excessive proliferation
appears to be a major unfavorable feature of pancreatic
cancer [2]. Investigations in inducing programmed cell
death and deepening the understanding of molecular
mechanisms may provide important value to develop new
therapeutic options.
Sophora flavescens ait (kushen), a traditional Chinese
herb, has been used as folk medicine for many kinds of
diseases. As one of the major components of Sophora fla-
vescens ait, oxymatrine has exhibited various pharmaco-
logical effects such as anti-hepatitis virus infection, anti-
hepatic fibrosis, anti-inflammation, anti-anaphylaxis and
other immune-regulation [3-6]. Some previous studies
have also reported anti-cancer activity of oxymatrine in
human gastric cancer cells and human breast cancer cells
[7,8]. In the present study, we aim to determine the anti-
cancer effect of oxymatrine on human pancreatic cancer




RPMI 1640 medium was obtained from Gibco BRL. New-
born bovine serum was supplied by Sijiqing Biotechnology
Co. (Hangzhou, China). Monoclonal antibodies to Bcl-2,
Bax, Bid, Bad, Bcl-x (L/S), HIAP-1, HIAP-2, XIAP, NAIP,
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Livin, Survivin, cytochrome c, caspase 3 and b-actin were
purchased from Cell Signal, USA. Oxymatrine was pur-
chased from the National Institute for Pharmaceutical and
Biological Products, Beijing, China. The drug was dis-
solved in DMSO with the stock concentration of 10 mg/
mL. It was further diluted in culture medium with the
final DMSO concentration < 1%. 3-(4, 5-dimethylthiazol-
2-yl)-2, 5-diphenyltetrazolium bromide (MTT) and propi-
dium iodide (PI) were purchased from Sigma Chemical
Corporation, USA.
Cell culture
Human pancreatic cancer cell lines (PANC-1, BxPC-3 and
AsPC-1) were provided by Cancer Institute of Zhejiang
University. PANC-1, BxPC-3 and AsPC-1 cells were main-
tained in RPMI 1640 medium (Gibco BRL) supplemented
with 10% heat-inactivated fetal bovine serum (Si-Ji-Qing
Biotechnology Co, Hangzhou, China), 100 U/mL penicillin
and 100 μg/mL streptomycin at 37°C in a 5% CO2
atmosphere.
Cell viability assay
PANC-1, BxPC-3 and AsPC-1 cells (1 × 104 in 100 μL)
were seeded on 96-well plates in triplicate respectively.
Following a 24-h culture at 37 °C, the medium was
replaced with fresh medium containing vehicle control or
various concentrations of oxymatrine in a final volume of
200 μL. Cells were incubated at 37 °C for 24 h. Then
50 μL of MTT (2 mg/mL in PBS) was added to each well,
incubated for an additional 4 h, the plate was centrifuged
at 1000 r/min for 10 min, then the medium was removed.
The MTT formazan precipitate was dissolved in 100 μL
DMSO, shaken mechanically for 10 min and then read
immediately at 570 nm by a plate reader (Opsys MR,
Denex Technology, USA).
Flow cytometry
PANC-1 cells were treated with different concentration
of oxymatrine (0, 0.5, 1 and 2 mg/mL) for 48 h at cell
density of 2 × 105 cells/mL, and then stained with
Annexin V-FITC and PI (Sigma, USA). Annexin V-FITC
positive and PI negative cells were considered as apop-
totic cells.
RT-PCR assay
PANC-1 cells 1 × 105 were seeded on 24-well plate. After
24-h culture, cells were treated with 0.5, 1, 2 mg/mL oxy-
matrine and vehicle for 48 h. Total RNA was extracted
using Trizol (Invitrogen, USA). cDNA synthesis was
performed using a RNA PCR kit (TaKaRA Biomedicals,
Osaka, Japan) with the supplied oligo dT primer
(Table 1). Samples were separated on 20 g/L agarose gel
and visualized with ethidium bromide staining under UV
light.
The PCR primer and regimen were as following: 5’-
GTGGAGGAGCTCTTCAGGGA-3’, 5’-AGGCACCCA
GGGTGATGCAA-3’ for Bcl-2 (304 bp, 42 cycles); 5’-
GGCCCACCAGCTCTGAGCAGA-3’, 5’- GCCACGT
GGGCGGTCCCAAAGT -3’ for Bax (479 bp, 42 cycles);
5’-CAGTGATCTGCTCCACATTC-3’ 5’-TCCAGCTAG-
GATGATAGGAC-3’ for Bad (340 bp, 40 cycles); 5’-
GACCCGGTGCCTCAGGA-3’, 5’-ATGGTCACGGTC
TGCCA-3’ for Bid (586 bp, 40 cycles); 5’-TTGGAC
AATGGACTGGTTGA-3’, 5’-GTAGAGTGGATGGT-
CAGTG-3’ for Bcl-X (l/s) (780/591 bp, 42 cycles); 5’-GC
CTGATGCTGGATAACTGG-3’, 5’-GGCGACAGAAAA
GTCAATGG-3’ for HIAP-1 (349 bp, 38 cycles); 5’-GCCT
GATGCTGGATAACTGG-3’, 5’-GCTCTTGCCAATT
CTGATGG-3’ for HIAP-2 (361 bp, 38 cycles); 5’-GTGAC-
TAGATGTCCACAAGG-3’, 5’-CTTGAGGAGTGTC
TGGTAAG-3’ for XIAP (368 bp, 38 cycles); 5’-TTATACC
AGCGCCAGTTTCC-3’, 5’-TGGTGGAACTAAGGGAG
AGG-3’ for NAIP (299 bp, 38 cycles); 5’-CTCCTTCTAT-
GACTGGC-3’, 5’-ACACTCAGCACAGACC-3’ for Livin
(496 bp, 38 cycles); 5’-CAGATTTGAATCGCGGGACCC-
3’, 5’-CCAAGTCTGGCTCGTTCTCAG-3’ for Survivin
(206 bp, 38 cycles); 5’-GGAGTCCTGTGGCATCCACG-3’
5’-CTAGAAGCATTTGCGGTGGA-3’ for b-actin (322
bp, 30 cycles). The PCR conditions were denaturation at
94°C for 1 min, annealing at 56°C for 1 min, and extension
at 72 °C for 2 min.
Western blotting
PANC-1 cells (5 × 106) treated with 0.5, 1 and 2 mg/mL
oxymatrine and vehicle respectively for 48 h were lysed by
4 g/L trypsin containing 0.2 g/L EDTA, then collected
after washed twice with phosphatebuffered saline (PBS,
pH 7.4). Total protein extract from PANC-1 cells was pre-
pared using cell lysis buffer [150 mmol/L NaCl, 0.5 mol/L
Tris-HCl (pH 7.2), 0.25 mol/L EDTA (pH 8.0), 10 g/L Tri-
ton X-100, 50 mL/L glycerol, 12.5 g/L SDS]. The extract
(30 μg) was electrophoresed on 12 g/L SDS-PAGE and
electroblotted onto polyvinylidene difluoride membrane
(PVDF, Millipore Corp., Bedford, MA) for 2 h in a buffer
containing 25 mmol/L Tris-HCl (pH 8.3), 192 mmol/L
glycine and 200 mL/L methanol. The blots were blocked
with 50 g/L nonfat milk in TBST washing buffer for 2 h at
room temperature and then incubated at 4 °C overnight
with antibodies. All antibodies were diluted in TBST
according to the manufacturer’s instructions. After washed
at room temperature with washing buffer, the blots were
labeled with peroxidase-conjugated secondary antibodies.
Statistical analysis
SPSS for Windows version 11.0 (SPSS Inc., Chicago, IL)
was used to complete all the analyses. Statistical signifi-
cance was determined by Student’s t-test. A P value of <
0.05 was considered statistically significant.
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Results
Oxymatrine inhibiting PANC-1, BxPc-3 and AsPC-1cells
viability
The inhibitory effect of oxymatrine on the growth of
PANC-1, BxPc-3 and AsPC-1 cells was assessed by the
MTT assay. The various concentrations of oxymatrine
inhibited the viability of PANC-1, BxPc-3 and AsPC-1 cells
in both a dose- and time-dependent manner (Figure 1). In
these three cell lines, PANC-1 was the most sensitive cell
line to oxymatrine. Thus in the following experiment,
PANC-1 was used according to the MTT assay.
At the concentration of 0.5-2 mg/mL of oxymatrine,
PANC-1 cells sharply decreased on viability. However,
higher concentration of oxymatrine (> 2 mg/mL) had a
saturated inhibitory effect. Thus we chose the concentra-
tion of 0.5, 1 and 2 mg/mL for further investigation of the
molecular mechanism. During the following experiment at
48 h, oxymatrine showed a significantly higher inhibiting
effect than that at 24 h. In contrast, there was no signifi-
cant difference in cell survival among prolonged treatment
for 72 h, and 96 h. Therefore, we choose the time point of
48 h for the further investigation.
Oxymatrine inducing PANC-1 cells apoptosis
Oxymatine-induced apoptotic cell death was found using
Annexin V-FITC/PI double stained flow cytometry.
Annexin V-FITC positive and PI negative cells, which
were considered as early apoptotic cells, increased in a
dose-dependent manner (Figure 2). Oxymatrine-treated
PANC-1 had increased apoptosis rates at concentration of
1 and 2 mg/mL than the control group (P < 0.05).
Oxymatrine regulating expression of Bcl-2 family
The Bcl-2 mRNA expression was reduced when PANC-1
cells were exposed to 1.0 and 2.0 mg/mL oxymatrine
compared with controls, while Bax and Bcl-xS mRNA
expressions were increased (Figure 3A). A significant
increase of Bax/Bcl-2 ratio was found in the oxymatrine
treated (1.0 and 2.0 mg/mL) groups compared with
controls as determined by densitometric measurements
(P < 0.05) (Figure 4A). Although the Bcl-xS/Bcl-xL ratio
increased in the oxymatrine treated groups compared
with controls, no significant difference was noted (Figure
4A). Oxymatrine did not alter the expression of Bid and
Bad mRNA levels (Figure 3A).
Oxymatrine regulated expression of IAP family
Compared with controls, the Livin mRNA expression was
remarkably down-regulated after treated with different
concentrations of oxymatrine (all P < 0.05), while the level
of Survivin mRNA expression did not decrease until
PANC-1 cells were exposed to high concentrations (1.0
and 2.0 mg/mL) of oxymatrine (Figure 4B). In contrast, no
apparent changes of HIAP-1, HIAP-2, XIAP and NAIP
mRNA expressions were found at different levels of oxy-
matrine treated group compared with controls (Figure 3B).
Oxymatrine releasing cytochrome c and activated
caspase-3
Oxymatrine treatment led to a dose-dependent release
of cytochrome c and activation of caspase-3 (Figure 5).
A remarkable increase of cytochrome c protein level
was monitored after oxymatrine treatment. The cleaved
caspase-3 protein was observed after treated with 0.5
mg/mL oxymatrine and then presented a sharp increase
as treated with higher concentration of oxymatrine.
Mitochondrial apoptotic pathway may be responsible for
cell death characteristics induced by oxymatrine.
Discussion
Insufficient or excessive cell death can lead to cancer [2].
Apoptosis plays an essential role for organ development,
homeostasis, and immune defense and provides mechan-
isms for the anti-cancer therapies. In the present study,
the growth and viability of human pancreatic cancer cells
were largely inhibited by the extract of traditional Chi-
nese herb oxymatrine. Furthermore, oxymatrine can
induce cell apoptosis in human pancreatic cancer. As this
Figure 1 The inhibitory effect of oxymatrine on the growth of PANC-1, BxPc-3 and AsPC-1cells. The inhibitory effects of oxymatrine on
the growth of PANC-1, BxPc-3 and AsPC-1 cells were observed in both a dose- and time-dependent manner. PANC-1, BxPc-3 and AsPC-1 cells
treated with different concentrations of oxymatrine (0.25, 0.5, 1, 2, 4, 6 and 10 mg/mL) and the cell survival rates were calculated for different
periods of time (24, 48, 72 and 96 h).
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pilot study would be extended to further cell lines and
primary cultures, induction of apoptosis of pancreatic
cancer with traditional Chinese anti-cancer drugs would
be probably a promising approach of pancreatic cancer.
Multiple signal pathways are involved in the regulation
of apoptosis and the molecular regulators have been iden-
tified. Among them, the Bcl-2 family plays a central role in
the activation of caspases and dominates the regulation of
apoptosis [9-11]. Some Bcl-2 family members can promote
cell death, such as Bax, Bad, Bid, Bcl-xS while others pro-
mote cell survival, like Bcl-2, Bcl-xL. The relative balance
between these anti- and pro-apoptotic Bcl-2 family mem-
bers influences the susceptibility of cells to a death signal.
In this study, oxymatrine-induced apoptotic cell death was
involved in down-regulation of Bcl-2 and up-regulation of
Bax. Bax directly or indirectly generates cell death signals
while Bcl-2 is the dominant inhibitor of Bax. The Bax/Bcl-
2 ratio has been reported to determine the eventual out-
come (apoptosis or survival) [12]. Our result demonstrated
about 5 and 9 fold Bax/Bcl-2 ratios at the treatment of 1.0
and 2 mg/ml concentration of oxymatrine respectively,
compared with controls, which suggested that the altera-
tion of Bax/Bcl-2 expression was associated with oxyma-
trine-induced pancreatic cancer cells apoptosis. Besides
Bax/Bcl-2 ratio, the Bcl-xS/Bcl-xL ratio also plays a major
role in the fate of the cell following an apoptotic stimulus.
The dominant inhibitor Bcl-xS can abrogate Bcl-2 func-
tion via its binding to Bcl-2, which prevents Bcl-2 from
Figure 2 Apoptosis analysis of PANC-1 cells. Apoptosis analysis of PANC-1 cells induced by different concentration of oxymatrine (0, 0.5, 1
and 2 mg/ml; from left to right panel) for 48 h, using flow cytometer with Annexin V-FITC/PI binding assay.

Figure 3 The effect of oxymatrine on the mRNA expression of Bcl-2 and IAP family. The effect of oxymatrine on the mRNA expression of
Bcl-2 family and IAP family. PANC-1 cells were treated with different concentration (0, 0.5, 1 and 2 mg/ml) of oxymatrine for 48 h.
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interaction with Bax and thus leaves Bax unopposed in its
cell-death effectors function [13]. Although Bcl-xS/Bcl-xL
ratio appeared to be very important in deciding cell fate in
a number of cell types [14-16], the role of Bcl-xL in pan-
creatic cell apoptosis is still unknown. In this study, Bcl-
xS/Bcl-xL ratio was increased in oxymatrine treated
groups compared with controls. However, no statistical
significance was noted and whether the Bcl-xL gene is
involved in the oxymatrine-induced apoptosis needs
further verification.
Caspases are the central components in the apoptotic
response. Both intrinsic (ie mitochondrial) and extrinsic
(ie death receptor) pathways can activate caspases. In
mitochondrion-dependent apoptosis, cytochrome c
released from the mitochondria can activate the initiator
caspase-9 and the effector caspase-3, which play key roles
in both intrinsic and extrinsic pathways [17,18]. Bcl-2
exerts control of mitochondrial permeability and pre-
venting the cytochrome C release while Bax can promote
mitochondrial permeability. Thus the elevated Bax/Bcl-2
ratio would indicate the release of cytochrome c. The
Western blotting analysis showed that a dose-dependent
release of cytochrome c and activation of caspase-3 upon
48 h treatment was consistent with the PCR results. This
study demonstrates that oxymatrine treatment leads to
the release of cytochrome c and activation of caspase-3.
Apoptosis may also be inhibited by a variety of proteins
including members of the inhibitors of apoptosis (IAP)
family [19]. IAPs comprise a family of structurally similar
proteins, such as HIAP-1, HIAP-2, XIAP, NAIP, Livin and
Survivin, largely over-expressed by most tumors. They
promote tumor cell survival after a wide variety of apopto-
tic stimuli elicited via intrinsic and extrinsic pathways [19].
 
Figure 4 The ratio of Bax/Bcl-2 changes and Survivin/Actin and Livin/Actin changes. The ratio of Bax/Bcl-2 changes and Survivin/Actin and
Livin/Actin changes after different treatments as determined by densitometric measurements, *: P < 0.05 as compared with controls.

Figure 5 The effect of oxymatrine on release of mitochondrial
cytochrome c and activation of caspase-3. The effect of
oxymatrine on release of mitochondrial cytochrome c and
activation of caspase-3. PANC-1 cells were treated with different
concentration (0, 0.5, 1 and 2 mg/ml) of oxymatrine for 48 h. A 1%
concentration of DMSO was used for control.
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Our results revealed that oxymatrine-induced apoptosis
was related to down-regulation of Livin and Survivin
expressions. Livin (BIRC7), a novel identified member of
IAP family, selectively binds the endogenous IAP antago-
nist SMAC and caspase-3, caspase-7, and caspase-9, as a
result, inhibits apoptosis [19-21]. Survivin can also bind
the effector cell death proteases caspases-3 and -7 and
inhibit caspase activity and cell death. Furthermore, Survi-
vin-(hepatitis B X-interacting protein) complexes can bind
pro-caspase-9 and selectively suppresses apoptosis via the
mitochondria/cytochrome c pathway [19,22]. Livin and
Survivin expressions were found in primary and cultured
tumor cells and their overexpression was associated with
poor prognosis [23-25]. In this study, Livin expression was
markedly inhibited by oxymatrine in a dose-dependent
manner, while the expression of Survivin was only down-
regulated at a relative high dose of oxymatrine.
Conclusions
In this study, a dose- and time-dependent oxymatrine-
induced pancreatic cancer cell death via increasing pro-
apoptotic Bax expression and decreasing anti-apoptotic
Bcl-2 and Bcl-xS expression result in the release of cyto-
chrome to cytosol, followed by activation of caspapse-3
and finally lead to cell apoptosis. Moreover, down-regu-
lation of IAP family members (Livin and Survivin) is
likely to be involved in the oxymatrine-induced apopto-
sis. These findings may provide a promising approach of
pancreatic cancer’s therapy based on traditional Chinese
medicine.
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